Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
18 Dec 2025
See more Inside Socialpoint: Growing a global gaming hub in BarcelonaInside Socialpoint: Growing a global gaming hub in Barcelona
-
17 Dec 2025
See more SEAT & CUPRA invests €4.85 million in a new Circular Economy Hub in BarcelonaSEAT & CUPRA invests €4.85 million in a new Circular Economy Hub in Barcelona
-
10 Dec 2025
See more Socialpoint inaugurates its new hub in Barcelona, the main Take-Two Interactive facilities in EuropeSocialpoint inaugurates its new hub in Barcelona, the main Take-Two Interactive facilities in Europe
-
27 Nov 2025
See more easyJet chooses Barcelona for its first Digital Hub in EuropeeasyJet chooses Barcelona for its first Digital Hub in Europe
